Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: Molecular clues for its activity in nephropathy

Nephrology Dialysis Transplantation

Volumn 10, Issue 2, 1995, Pages 175-184

  Caenazzo, C ^a   Garbisa, S ^a   Ceol, M ^a   Baggio, B ^a   Borsatti, A ^a   Marchi, E ^b   Gambaro, Giovanni ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Alfa Wassermann SpA   (Italy)

Author keywords

Glycosaminoglycans; Heparin; Mesangium; Proliferation; Proteoglycans

Indexed keywords

BIGLYCAN; CHONDROITIN SULFATE; DECORIN; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; PROTEOGLYCAN; SULFATE;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GLOMERULUS; KIDNEY CELL CULTURE; KIDNEY DISEASE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SULFATION;

ANIMAL; CELL DIVISION; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHONDROITIN SULFATES; CYTOSKELETAL PROTEINS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARITIN SULFATE; IMMUNOENZYME TECHNIQUES; KIDNEY DISEASES; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; SULFATES; SUPPORT, NON-U.S. GOV'T;

EID: 0028937724     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a091054     Document Type: Article

References (26)

1. Castellot JJ, Hoover RL, Harper PA, Kamovsky MJ. Heparin and glomerular epithelial cell-secreted heparinlike species inhibit mesangial cell proliferation. Am J Pathol 1985; 120: 427-435
2. Diamond JR, Kamovsky MJ. Non anticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. RenaI Physiol 1986; 9: 366-374
3. Adler S, Eng B. Reversal of inhibition of rat glomerular epithelial cell growth by growth factors. Am J Pathol 1990; 136: 557-563
4. Purkerson ML, Tollefsen DM, Klahr S. N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 1988; 81: 69-74
5. Gambaro G, Cavazzana AO, Luzzi P et al. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Ini 1992; 42: 285-291
6. Gambaro G, Venturini AP, Noonan DM et al. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy in the rat. Kidney Int 1994; 46: 797-806
7. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S. Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res 1982; 26: 227-240
8. Thomas GJ, Mason RM, Davies M. Characterization of proteoglycans synthesized by human adult glomerular mesangial cell in culture. Biochem J 1991; 277: 81-88
9. Noonan DM, Fulle A, Valente P et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with Iaminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266: 22939-22947
10. Harper PA, Robinson JM, Hoover RL, Wright TC, Kamovsky MJ. Improved methods for culturing rat glomerular cells. Kidney Int 1984; 26: 875-880
11. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brister RL, Striker GE. Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 1988; 33: 677-684
12. Tiozzo R, Cingi MR, Reggiani D et al. Effect of the desulfatation of heparin on its anticoagulant and antiproliferative activity. Thrombos Res 1993; 70: 99-106
13. Olgemoller B, Schleicher E, Nerlich A, Wagner EM, Gerbitz KD. Isolation, characterization and immunological determination of basement membrane-associated heparan sulfate proteoglycan. Biol Chem Hoppe-Seyler 1989; 370: 1321-1329
14. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-/! regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37: 689-695
15. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989; 9: 1-20
16. Vijayagopal P, Ciolino HP, Radhakrishnamurthy B, Berenson GS. Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while supressing cellular proliferation. Atherosclerosis 1992; 94: 135-146
17. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE. Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest 1991; 64: 446-456
18. Wright TC Jr, Castellot JJ Jr, Petitou M, Lormeau JC, Choay J, Kamovsky MJ. Structural determinants of heparin’s growth inhibitory activity. Interdependence of oligosaccharide size and charge. J Biol Chem 1989; 264: 1534-1542
19. Lark MW, Wight TN. Modulation of proteoglycan metabolism by aortic smooth muscle cells grown on collagen gels. Arteriosclerosis 1986; 6: 638-650
20. Hassell JR, Kimura JH, Hascal VC. Proteoglycan core protein families. Ann Rev Biochem 1986; 55: 539-567
21. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Anna Rev Biochem 1991; 60: 443-475
22. Tan EML, Levine E, Sorger T et al. Heparin and endothelial cell growth factor modulated collagen and proteoglycan production in human smooth muscle cells. Biochem Biophys Res Commun 1989; 163: 84-92
23. Nader HB, Buonassisi V, Colburn P, Dietrich CP. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J Cell Physiol 1989; 140: 305-310
24. Vogel K.G, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223: 587-597
25. Winnemoller M, Schon P, Vischer P, Kresse H. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 1992; 59: 47-55
26. Taraboletti G, Morigi M, Figliuzzi M, Giavazzi R, Zoja C, Remuzzi G. Thrombospondin induces glomerular mesangial cell adhesion and migration. Lab Invest 1992; 67: 566-571